AU2003276488A1 - High purity ondansetron hydrochloride dihydrate and process for its synthesis - Google Patents
High purity ondansetron hydrochloride dihydrate and process for its synthesisInfo
- Publication number
- AU2003276488A1 AU2003276488A1 AU2003276488A AU2003276488A AU2003276488A1 AU 2003276488 A1 AU2003276488 A1 AU 2003276488A1 AU 2003276488 A AU2003276488 A AU 2003276488A AU 2003276488 A AU2003276488 A AU 2003276488A AU 2003276488 A1 AU2003276488 A1 AU 2003276488A1
- Authority
- AU
- Australia
- Prior art keywords
- synthesis
- high purity
- hydrochloride dihydrate
- ondansetron hydrochloride
- ondansetron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- FELGMEQIXOGIFQ-UHFFFAOYSA-N Ondansetron Chemical compound CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960005343 ondansetron Drugs 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP0203547 | 2002-10-17 | ||
HU0203547A HU225885B1 (en) | 2002-10-17 | 2002-10-17 | Process for producing ondansetron hydrochlorid dihydrate of high purity |
PCT/HU2003/000081 WO2004035567A1 (en) | 2002-10-17 | 2003-10-16 | High purity ondansetron hydrochloride dihydrate and process for its synthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003276488A1 true AU2003276488A1 (en) | 2004-05-04 |
Family
ID=89980861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003276488A Abandoned AU2003276488A1 (en) | 2002-10-17 | 2003-10-16 | High purity ondansetron hydrochloride dihydrate and process for its synthesis |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003276488A1 (en) |
HU (1) | HU225885B1 (en) |
WO (1) | WO2004035567A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2565854A1 (en) | 2004-05-07 | 2005-11-17 | Taro Pharmaceutical Industries Ltd. | Process for preparing ondansetron hydrochloride dihydrate having a defined particle size |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8630071D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
ZA200305338B (en) * | 2001-01-11 | 2004-07-12 | Teva Pharma | An improved process for preparing pure ondansetron hydrochloride dihydrate. |
-
2002
- 2002-10-17 HU HU0203547A patent/HU225885B1/en unknown
-
2003
- 2003-10-16 AU AU2003276488A patent/AU2003276488A1/en not_active Abandoned
- 2003-10-16 WO PCT/HU2003/000081 patent/WO2004035567A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HU225885B1 (en) | 2007-11-28 |
HUP0203547A3 (en) | 2004-10-28 |
HU0203547D0 (en) | 2002-12-28 |
HUP0203547A2 (en) | 2004-06-28 |
WO2004035567A1 (en) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003238980A1 (en) | Process for obtaining of bulk monocrystallline gallium-containing nitride | |
IL196010A0 (en) | Pyrazole derivatives and process for the production thereof | |
AU2003264400A1 (en) | Process for producing arylamine | |
AU2003278355A1 (en) | Process | |
SG115596A1 (en) | Process for preparing tert-butanol | |
SI1403264T1 (en) | Process for the industrial synthesis of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxydimethylester | |
AU2003218704A1 (en) | Process for preparing 2-aminoindan derivatives | |
AU2003211279A1 (en) | Process for producing proanthocyanidine-rich material | |
AU2003263622A8 (en) | Process for preparing prostaglandin derivatives and starting materials for the same | |
EP1547993A4 (en) | Process for preparation of spirofluorenols | |
AU2003250151A1 (en) | Method for the synthesis of anthracycline-peptide conjugates | |
IL165137A0 (en) | Process for the preparation of thioalkylamine derivatives | |
AU2002367890A1 (en) | Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate | |
AU2003287174A1 (en) | Process for synthesizing antifolates | |
AU2003263586A1 (en) | A process for the synthesis of bisbenzimidazoles and its derivations | |
AU2003261766A1 (en) | Process for production of 4-alkylphenols | |
AU2003241100A1 (en) | Process for preparing high purity azithromycin | |
AU2003276488A1 (en) | High purity ondansetron hydrochloride dihydrate and process for its synthesis | |
AU2003292820A1 (en) | 4-amino-5-methylpyrazole derivatives and process for production thereof | |
AU2003224327A1 (en) | Process for the synthesis of peptides | |
AU2002330736A1 (en) | An improved process for the synthesis of pharmacologically active (z/e)-guggulsterones | |
AU2003263197A1 (en) | Process | |
AU2003254791A1 (en) | Process for production of amides | |
AU2003235129A1 (en) | Process for preparation of 2-aminoketones | |
AU2003295132A1 (en) | Process for production of deoxygalactonojirimycin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |